Eli Lilly’s LLY first-quarter revenue grew 45%, as combined sales for Mounjaro (diabetes) and Zepbound (obesity) rose ...

Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong ...

Shares of Eli Lilly fell sharply Thursday morning after the pharmaceutical giant's lowered profit projections outweighed ...

LLY has delivered impressive returns of 15% year-to-date (as of April 30), outperforming the S&P 500’s 5% decline during the ...

The deal is expected to give the US access to Ukraine’s valuable rare earth minerals while providing Kyiv a measure of ...

The U.S. and Ukraine have announced an economic deal after a weekslong press by President Donald Trump. He wanted Kyiv to ...

President Donald Trump will deliver remarks on “ Investing in America ” following the release of a worrisome economic report ...

Musk has served Tesla well, but now the EV company needs someone like Tim Cook who thrives at fine-tuning processes.

Chinese exports show the impact of U.S trade war, Meta’s stand-alone AI app will compete with rivals, and more news to start ...

Novo Nordisk A/S faces challenges in the obesity market, but new trials and innovations offer hope. Read more on NVO stock ...

Pfizer is deeply undervalued, and has a high dividend yield, and I see tons of institutions and analysts buying the dip. Read ...